U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07404566) titled 'Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C Patients' on Feb. 05.
Brief Summary: This study evaluates a target population of patients with Hepatitis C virus (HCV) infection, including those with complications like liver cirrhosis (LC) and hepatocellular carcinoma (HCC), to investigate the diagnostic utility of a specific panel of microRNAs (miRNAs). The intervention involves quantifying the plasma expression (PE) levels of MiR-21, 1246, 205, 29a-3p, and 497 via PCR and comparing them to healthy controls to determine their efficacy as biomarkers. The primary outcome is to assess the sensitivity, specif...